干白素-27在慢性淋巴细胞白血病中增强了CD8+T细胞介导的抗瘤免疫力
Giulia Pagano1, Iria Fernandez Botana1, Marina Wierz2
1Tumor Stroma Interactions, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Haematologica
|June 22, 2023
概括
干白素27 (IL-27) 在慢性淋巴细胞白血病 (CLL) 中表现出强大的抗瘤作用. 这种细胞因子会重新激活T细胞,这表明它可能是CLL的有前途的新疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 慢性淋巴细胞白血病 (CLL) 细胞依赖瘤微环境 (TME) 才能生存.
- 亲炎性细胞因子正在被探索作为一种新的治疗方法,以促进免疫系统对抗癌症.
- 介素27 (IL-27) 是一种细胞因子,在不同癌症中具有不同的作用.
研究的目的:
- 研究IL-27在慢性淋巴细胞白血病 (CLL) 中的作用.
- 探索IL-27作为CLL治疗剂的潜力.
主要方法:
- 使用了Eμ-TCL1和EBI3淘汰小鼠模型和人类CLL患者样本.
- 通过基因分析分析了白血病脏和特征T细胞子集.
- 评估T细胞活性和抗瘤功能,与IL-27治疗一起,ex vivo.
主要成果:
- 缺少IL-27加速了CLL的发展,并增加了小鼠的TME免疫抑制.
- IL-27影响了与激活和细胞毒性相关的CD8+T细胞转录特征.
- IL-27增强了CD8+T细胞的抗瘤活性,并从CLL患者中重新激活了T细胞.
- 在临床前和临床环境中,在CLL进展期间观察到IL-27血清水平的降低.
结论:
- 在慢性淋巴细胞白血病中,IL-27具有显著的抗瘤作用.
- 作为潜在的治疗或辅助治疗CLL,IL-27具有前景.
更多相关视频
相关概念视频
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Cytotoxic T Cells-mediated Immune Response
998
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
998
T Cell Activation and Clonal Selection
837
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
837


